Lake Forest Pharma Investments

Lake Forest Pharma Investments LLC is a private investment firm focused on the pharmaceutical and life sciences sectors. Founded in 2015 by Donald S. O'Kelly, the former CEO of PharMEDium Healthcare, the firm served as a strategic investment vehicle for healthcare-related ventures. It is most notably recognized as a lead investor in Altan Pharma Limited, an Irish specialty pharmaceutical company specializing in injectable medications for hospital use. Lake Forest Pharma Investments supported Altan’s development of unique drug formulations, such as intravenous acetaminophen, and its expansion into the United States market. Following the acquisition of Altan Pharma by Ethypharm in 2021 for approximately $81 million, the firm successfully realized its primary investment. The company is currently inactive following the exit of its major portfolio holdings.